These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12532545)

  • 1. [Open trial using ACE inhibitor. Left ventricular hypertrophy diminishes].
    Arend U; Albrecht S; Meisel E; Schmidt J
    MMW Fortschr Med; 2002 Nov; 144(48):51. PubMed ID: 12532545
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of ACE inhibitor spirapril on left ventricular hypertrophy].
    Arend U; Albrecht S; Meisel E; Schmidt J
    Fortschr Med Orig; 2002 Dec; 120(4):147-50. PubMed ID: 12613273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of left ventricular hypertrophy by spirapril.
    Eichstädt H; Sierakowski B; Eskötter H; Cordes M; Kreuz D
    Blood Press Suppl; 1994; 2():93-4. PubMed ID: 8061856
    [No Abstract]   [Full Text] [Related]  

  • 4. [Management of hypertensive patients with left ventricular hypertrophy].
    Ambrosioni E
    Presse Med; 2002 Oct; 31 Spec No 2():S13-6. PubMed ID: 12355999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy].
    Ovchinnikov AG; Serbul VM; Ageev FT
    Ter Arkh; 2009; 81(5):64-71. PubMed ID: 19537590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative long-term effects of spironolactone in conjunction with an angiotensin-converting enzyme inhibitor on left ventricular mass and diastolic function in patients with essential hypertension.
    Sato A; Hayashi M; Saruta T
    Hypertens Res; 2002 Nov; 25(6):837-42. PubMed ID: 12484506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitors and effects on left ventricular hypertrophy.
    Dahlöf B
    Blood Press Suppl; 1994; 2():35-40. PubMed ID: 8061844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of blood pressure reduction with trandolapril and enalapril on left ventricular hypertrophy and exercise tolerance.
    Leonetti G; Fogari R; Mazzola C; Pasotti C; Ponti GB; Marelli C; Zanchetti A
    J Hypertens Suppl; 1993 Dec; 11(5):S356-7. PubMed ID: 8158420
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in left ventricular dimensions and haemodynamics during antihypertensive treatment with spirapril for 36 months.
    Otterstad JE; Froeland G
    Blood Press Suppl; 1994; 2():69-72. PubMed ID: 8061849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of isradipine and spirapril on left ventricular hypertrophy and resistance arteries.
    Thürmann PA; Stephens N; Heagerty AM; Kenedi P; Weidinger G; Rietbrock N
    Hypertension; 1996 Sep; 28(3):450-6. PubMed ID: 8794832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan.
    Avanza AC; El Aouar LM; Mill JG
    Arq Bras Cardiol; 2000 Feb; 74(2):103-17. PubMed ID: 10904284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association between angiotensin converting enzyme gene, chymase gene and regression of left ventricular hypertrophy in patients treated with angiotensin converting enzyme inhibitors].
    He H; Li LM; Cao WH; Liu MZ; Sun NL; Lü J; Hu YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):756-60. PubMed ID: 15555355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood pressure lowering by the ACE-inhibitor spirapril. "24-hour efficacy of real once daily application of spirapril (HERAS Study)"].
    Düsing R; Müller U
    MMW Fortschr Med; 2003 Oct; 145(40):46. PubMed ID: 14603605
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of angiotensin-converting enzyme inhibitors on left ventricular hypertrophy in patients with chronic glomerulonephritis and pronounced kidney failure].
    Diadyk AI; Bagriĭ AE; Lebed' IA; Iarovaia NF; Shchukina EV; Gaĭdukov VO; Gritsenko PV; Diadyk IA
    Ter Arkh; 1997; 69(6):24-7. PubMed ID: 9297267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Losartan versus enalapril in the reduction of left ventricular hypertrophy secondary to systemic arterial hypertension].
    Uribe Flores JD; Hernández Jácome M; Guevara Dondé J; Segura X
    Arch Cardiol Mex; 2004; 74(3):192-9. PubMed ID: 15559871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Converting enzyme inhibition and left ventricular hypertrophy.
    Fagard R
    Eur Heart J; 1995 Dec; 16(12):1748-9. PubMed ID: 8681996
    [No Abstract]   [Full Text] [Related]  

  • 18. Determinants of left ventricular mass reduction in essential hypertension.
    Grodzicki T; Messerli FH; Soria F; Aristizabal D; Frohlich ED
    J Hypertens Suppl; 1993 Dec; 11(5):S364-5. PubMed ID: 8158424
    [No Abstract]   [Full Text] [Related]  

  • 19. Left ventricular systolic function after marked reduction of ventricular hypertrophy induced by 5 years' enalapril treatment.
    González-Juanatey JR; Pose Reino A; García Acuña JM; Castelo Fuentes V; Amaro Gendón A; Calvo Gómez C; Gil de la Peña M
    Eur Heart J; 1995 Dec; 16(12):1981-7. PubMed ID: 8682036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvascular angina in systemic hypertension: diagnosis and treatment with enalapril.
    Iriarte MM; Caso R; Murga N; López de Argumedo M; Sagastagoitia D
    Am J Cardiol; 1995 Nov; 76(13):31D-34D. PubMed ID: 7495215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.